A revolution in transplant medicine - Will we be able to order artificial hearts? | DW Documentary

Tissue Engineering and Artificial Organs: A Pursuit to Overcome Organ Shortage

Key Concepts:

• Tissue Engineering: Modifying or creating new organs from existing tissues.
• Desellularization & Recellularization: Removing cells from an organ scaffold and repopulating it with new cells.
• Organoids: Miniature, lab-grown organs mimicking the structure and function of real organs.
• Pluripotent Stem Cells: Cells capable of differentiating into any cell type in the body.
• Artificial Hearts: Mechanical devices designed to replace or assist failing hearts.
• Brain Death: The irreversible cessation of all brain function, a key factor in organ donation regulations.
• Xenotransplantation: Transplantation of living cells, tissues or organs from one species to another. (Not explicitly discussed, but relevant context)

I. The Critical Organ Shortage & Global Disparities

The global demand for organ transplants far exceeds the available supply. In 2023, nearly 8,400 people in Germany alone were on waiting lists, primarily for kidneys. However, fewer than 1,000 organs were donated after death, equating to only 11.4 donors per 1 million citizens. This contrasts sharply with France (26 donors/million) and Spain (50 donors/million), though these countries also face waiting lists. The core problem is the disparity between the number of patients needing organs and the limited number of available donors, leading to preventable deaths while patients await transplantation.

II. Tissue Engineering: Reprogramming Existing Organs

Dr. Eriselda Keshi at the Charité University Hospital in Berlin is exploring tissue engineering as a potential solution. Her work focuses on utilizing existing organ structures – specifically, a rat liver – and “reprogramming” it to function as a human organ. This involves a two-step process:

• Desellularization: The rat liver is treated with chemical solutions (described as “soaps”) to remove all existing cells, leaving behind a colorless, transparent “ghost organ” – a scaffold of extracellular matrix and vascular structures. This process effectively “moves out the inhabitants” (cells) to make space for new ones.
• Recellularization: The scaffold is then repopulated with human cells. Dr. Keshi’s initial focus is on vascular cells, injected via the portal vein, to establish a functional blood supply within the scaffold. Following vascularization, the team aims to introduce pancreatic islet cells (specifically, the islets of Langerhans responsible for insulin production) to transform the liver into a functional human pancreas.

III. Creating Organs from Scratch: The Promise of Organoids

Minoru Takasato at the RIKEN Institute in Japan is pursuing a more ambitious approach: creating organs de novo (from scratch) using stem cell technology. Japan faces a particularly acute organ shortage, with only one donor per million inhabitants and waiting times potentially extending to 15 years for a kidney.

• Stem Cell Differentiation: Takasato’s team utilizes pluripotent stem cells – cells capable of becoming any cell type – derived from human skin cells. These cells are reprogrammed and then cultivated in an environment mimicking embryonic development.
• Organoid Formation: By exposing the stem cells to specific growth factors, they are guided to differentiate into the desired tissue type, forming miniature, 3D structures called organoids. Takasato’s team has successfully created kidney organoids, which exhibit functional nephrons (the filtering units of the kidney).
• Vascularization Challenge: A key limitation of current organoid technology is their size. Nutrient delivery is limited, hindering growth. Takasato’s team is exploring methods to vascularize the organoids – integrating them with a blood vessel network – by transplanting them into mice and observing the growth of the mouse’s blood vessels into the organoid. They are also working on creating a complete urinary tract system (bladder and ureter) to enable proper urine drainage and prevent organoid swelling.

IV. Advancements in Artificial Organs: The Real Heart Prototype

While tissue engineering and organoids are promising long-term solutions, artificial organs offer immediate potential. The Swedish company Real Heart is developing a fully artificial four-chamber heart, known as Real Heart.

• Biomimicry: The Real Heart is designed to mimic the function of a natural human heart, with two pumps (left and right sides), each containing an atrium and a ventricle, and integrated valves and pressure sensors.
• Functionality: The heart reacts to blood flow, adjusting its rate and strength similarly to a natural heart. It is powered by a cable connected to an external control unit and batteries.
• Clinical Trials & Advantages: The device is undergoing rigorous testing, including implantation in sheep, to demonstrate its safety and efficacy. Artificial hearts offer the advantage of immediate availability, bypassing the limitations of donor organ supply. Current data suggests a 5-year survival rate exceeding 60% for artificial hearts.

V. Ethical and Practical Considerations

The video highlights several challenges:

• Brain Death Recognition (Japan): Cultural and legal barriers in Japan regarding the recognition of brain death significantly limit post-mortem organ donation.
• Living Donation Regulations (Germany): German law restricts living donations to direct family members or those with close relationships to prevent coercion and financial exploitation.
• Animal Testing Ethics: The use of animals in testing artificial organs and organoids raises ethical concerns, but is deemed necessary to ensure safety and efficacy before human trials.
• Cost and Accessibility: The development and implementation of these technologies are expensive, potentially limiting access for many patients.

VI. The Path Forward & Concluding Remarks

Dr. Keshi emphasizes that while these advancements are promising, they do not negate the importance of increasing organ donation rates. “Of course, it raises the question of why organ donation rates are so low that we need to go to all this effort…” The pursuit of artificial organs and tissue engineering represents a paradigm shift in medicine, offering the potential to eliminate the agonizing wait for life-saving transplants. The combination of innovative technologies – from reprogramming existing organs to creating new ones from scratch – coupled with advancements in artificial organ design, holds the promise of a future where organ shortages are a thing of the past.

Notable Quote:

“We shouldn't have to wait for one person to die so that another can live. That's just absurd. And we have the technology available to change this.” – (Unattributed, but expressed by a researcher discussing the need for alternative solutions to organ shortage).